var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); ion" CONTENT="AIDS-related deaths among New York City s intravenous (IV) drug abusers are greatly underestimated, according to a report in the Nov. 11 Science magazine by Don Des Jarlais of the New York State Division of Substance Abuse Services, Rand L. Stoneburner of the New York City Department of Health, and their colleagues. "> "AIDS Toll Underestimated in IV Drug Users" < > // var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); > < > // var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); > CDC Daily UpdateImportant note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.
Click here to return to CDC Daily Update main menu
DonateNow
Print this article

"AIDS Toll Underestimated in IV Drug Users"

Science News (11/12/88) Vol. 134, No. 20, P. 311
Fackelmann, K.


Abstract: AIDS-related deaths among New York City's intravenous (IV) drug abusers are greatly underestimated, according to a report in the Nov. 11 Science magazine by Don Des Jarlais of the New York State Division of Substance Abuse Services, Rand L. Stoneburner of the New York City Department of Health, and their colleagues. Between 1982 and 1986, the city recorded 1197 official AIDS deaths among IV drug users. While researching narcotics-related death rates, however, Des Jarlais and his colleagues found an additional 2520 deaths that they believe were AIDS-related. Public health researchers have long suspected that officially recorded narcotics-related deaths, which have sharply risen since 1982, hide a large number of AIDS-related deaths. Stoneburner and his colleagues suggest that many addicts with AIDS-weakened immune systems succumb to tuberculosis, heart-valve infection, pneumonia, and other conditions that were not included among opportunistic infections that meet the strict Centers for Disease Control AIDS definition. Minority IV drug abusers seem most likely to be exposed to these pathogens and less likely to receive prompt treatment.
881112
AD880028

Copyright © 1988 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

< type="text/java "> var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); > < type="text/java " src="http://pagead2.googlesyndication.com/pagead/show_ads.js"> var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); >

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .